Kingsview Wealth Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
GAM
Kingsview Wealth Management's OGN Position: Q3 2025 in Review
Kingsview Wealth Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 48,505 shares — an estimated $470K sold.
Kingsview Wealth Management first reported a position in OGN in Q4 2021 and held it in 4 quarters. The position peaked at $542K in Q4 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.
- Kingsview Wealth Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
- Kingsview Wealth Management sold 48,505 Organon & Co shares in Q3 2025, an estimated $470K.
- Kingsview Wealth Management first reported a position in Organon & Co in Q4 2021 and held it in 4 quarters.
- Kingsview Wealth Management's Organon & Co position peaked at $542K in Q4 2024.
- 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.
Based on Kingsview Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.